Long S D, Quigley J P, Troll W, Kennedy A R
Carcinogenesis. 1981;2(9):933-6. doi: 10.1093/carcin/2.9.933.
Plasminogen activator (PA) activity was analyzed in normal and transformed 10T1/2 mouse fibroblasts treated with the tumor promoter 12-O-tetradecanoylphorbol-13-acetate (TPA) and the protease inhibitors antipain, leupeptin, and soybean trypsin inhibitor (SBTI). TPA induced PA activity in normal 10T1/2 cells was inhibited by antipain. Transformed 10T1/2 cells maintained high levels of PA activity which were not further stimulated by the addition of TPA. Similarly, antipain inhibited the PA activity of the transformed cultures. Leupeptin and SBTI had no effect. These findings, in light of the fact that antipain has been shown to suppress the promotional effect of TPA in X-ray induced malignant transformation, may suggest a definite role for proteases in the transformational event or maintenance of the transformed state.
在经肿瘤启动子十四烷酰佛波醇乙酯(TPA)处理以及用蛋白酶抑制剂抗蛋白酶、亮抑酶肽和大豆胰蛋白酶抑制剂(SBTI)处理的正常及转化的10T1/2小鼠成纤维细胞中,分析了纤溶酶原激活物(PA)活性。抗蛋白酶抑制了TPA诱导的正常10T1/2细胞中的PA活性。转化的10T1/2细胞维持高水平的PA活性,添加TPA不会进一步刺激该活性。同样,抗蛋白酶抑制了转化培养物的PA活性。亮抑酶肽和SBTI没有作用。鉴于抗蛋白酶已被证明可抑制TPA在X射线诱导的恶性转化中的促进作用,这些发现可能表明蛋白酶在转化事件或维持转化状态中具有明确作用。